Purpura

10 registered clinical trials studyying Purpura.

Status	Trial	Sponsor	Phase
Withdrawn	The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune NCT06291415	Hutchmed	Phase 1
Completed	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis NCT03499808	SWOG Cancer Research Network	Phase 2
Completed	Study to Assess DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Forearms a NCT01910831	The Center for Clinical and Cosmetic Research	Phase 4
Withdrawn	All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of NCT01882127	Shandong University	Phase 3
Completed	rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP NCT01734044	Shandong University	Phase 3
Withdrawn	Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatm NCT01734057	Shandong University	Phase 3
Completed	rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP NCT01525836	Shandong University	Phase 3
Completed	Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP) NCT01506414	Ming Hou	Phase 3
Unknown	A Novel Oral Natural Extract for the Treatment of Senile Purpura NCT01183910	Nexgen Dermatologics, Inc.	N/A
Completed	Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin NCT00272610	University of Michigan	Phase 2